Therapy of Helicobacter pylori: present medley and future prospective (Q26823120)

Helicobacter pylori infectious disease

main subject

Helicobacter infection

5 references

22 June 2019

11 September 2020

13 September 2020

5 July 2022

29 July 2022

1 reference

17 September 2019

1 reference

2 November 2019

2 references

PubMed publication ID

11 September 2020

2 references

PubMed publication ID

13 September 2020

1 reference

inferred from title

author

Amin Talebi Bezmin Abadi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Amin Talebi Bezmin Abadi

series ordinal

1

1 reference

language of work or name

1 reference

2014

1 reference

BioMed Research International

1 April 2014

9 references

23 March 2019

21 March 2019

22 June 2019

17 September 2019

2 November 2019

11 September 2020

13 September 2020

5 July 2022

29 July 2022

11 references

23 March 2019

21 March 2019

22 June 2019

17 September 2019

2 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

11 September 2020

13 September 2020

5 July 2022

29 July 2022

2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

124607

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

2 June 2020

copyright license

9 references

23 March 2019

21 March 2019

22 June 2019

17 September 2019

2 November 2019

11 September 2020

13 September 2020

5 July 2022

on focus list of Wikimedia project

29 July 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Helicobacter pylori infection: an overview in 2013, focus on therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Pathogenesis of Helicobacter pylori infection

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

H pylori antibiotic resistance: prevalence, importance, and advances in testing

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Fluoroquinolones and risk of Achilles tendon disorders: case-control study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Bismuth therapy in gastrointestinal diseases

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Helicobacter pylori research: historical insights and future directions

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Current options for the treatment of Helicobacter pylori

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Recent development of gastric cancer prevention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Treatment of Helicobacter pylori infection 2012.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Which Therapy for Helicobacter pylori Infection?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

A new look at anti-Helicobacter pylori therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Inflammation, immunity, and vaccine development for Helicobacter pylori.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Diagnosis and treatment in Helicobacter pylori infection.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Helicobacter pylori treatment in the era of increasing antibiotic resistance

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

High level of antimicrobial resistance in French Helicobacter pylori isolates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

The sequential therapy regimen for Helicobacter pylori eradication

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Sequential therapy for Helicobacter pylori eradication: a critical review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

"Rescue" regimens after Helicobacter pylori treatment failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Helicobacter pylori detection and antimicrobial susceptibility testing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Phagocytosis and persistence of Helicobacter pylori

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Clarithromycin resistance in Helicobacter pylori infection: does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

High eradication rates of Helicobacter pylori with a new sequential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Alkyl hydroperoxide reductase: a candidate Helicobacter pylori vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

A new highly effective short-term therapy schedule for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Helicobacter pyloritherapy: what is coming?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F124607

Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3988734

In vivo susceptibility of Campylobacter pylori

28 November 2018

1 reference

12 December 2020

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial

1 reference

12 December 2020

High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong

1 reference

12 December 2020

Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer

1 reference

12 December 2020

Recurrence of Helicobacter pylori infection after eradication therapy in Brazilian patients with peptic ulcer

1 reference

12 December 2020

Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium

1 reference

12 December 2020

2-Week Triple Therapy for Helicobacter pylori Infection is Better Than 1-Week in Clinical Practice: a Large Prospective Single-Center Randomized Study

1 reference

12 December 2020

Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country

1 reference

12 December 2020

A report card to grade Helicobacter pylori therapy

1 reference

12 December 2020

Treatment ofHelicobacter pyloriInfection

1 reference

12 December 2020

Diagnosis of Helicobacter pylori Infection

1 reference

12 December 2020

Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment

1 reference

12 December 2020

Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran

1 reference

12 December 2020

Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication

1 reference

12 December 2020

Comment to: "Different Antibiotic No Culture Eradication (DANCE) of Helicobacter pylori: an easy way to manage H. pylori eradication"

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/124607

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

24800203

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24800203%20AND%20SRC:MED&resulttype=core&format=json